Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lysozyme for COPD and Asthma With Sputum Symptoms
jRCT1080222009Phase 4
- Sponsor
- Eisai Co., Ltd.
- Start
- Jan 2013
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in chronic obstructive pulmonary disease (COPD) and asthma comparing Lysozyme hydrochloride with Placebo (2 arms).
02
Drugs
lysozyme
03
Conditions
chronic obstructive pulmonary disease (COPD)asthma
Beyond the preview
Go deeper on jRCT1080222009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222009.